Rocket Doctor AI Subsidiary Treatment.com Secures Year 2 NIH Funding to Advance AI-Powered Family Health History Tool
Delaware, June 16, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI” or the “Company”), a physician-built, AI-powered healthcare technology company focused on empowering doctors and expanding access to high-quality affordable care, today announced that its U.S.-based subsidiary, Treatment.com Inc. (“Treatment”), in collaboration with Rush River Research, has received confirmation of second-year funding from the National Institute on Mino
Delaware, June 16, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI” or the “Company”), a physician-built, AI-powered healthcare technology company focused on empowering doctors and expanding access to high-quality affordable care, today announced that its U.S.-based subsidiary, Treatment.com Inc. (“Treatment”), in collaboration with Rush River Research, has received confirmation of second-year funding from the National Institute on Minority Health and Health Disparities, part of the National Institutes of Health (“NIH”).
Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.